Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T17:04:53.210Z Has data issue: false hasContentIssue false
  • English
  • Français

Individual and joint effects of genetic polymorphisms in microRNA-machinery genes on congenital heart disease susceptibility

Part of: Basic Science

Published online by Cambridge University Press:  11 January 2021

Andrea Borghini Open the ORCID record for Andrea Borghini [Opens in a new window] ,
Cecilia Vecoli ,
Antonella Mercuri ,
Stefano Turchi  and
Maria Grazia Andreassi
Andrea Borghini*
Affiliation:
CNR Institute of Clinical Physiology, Pisa, Italy
Cecilia Vecoli
Affiliation:
CNR Institute of Clinical Physiology, Pisa, Italy
Antonella Mercuri
Affiliation:
CNR Institute of Clinical Physiology, Pisa, Italy
Stefano Turchi
Affiliation:
CNR Institute of Clinical Physiology, Pisa, Italy
Maria Grazia Andreassi
Affiliation:
CNR Institute of Clinical Physiology, Pisa, Italy
*
Author for correspondence: Dr A. Borghini, CNR Institute of Clinical Physiology, Via Moruzzi 1, Pisa 56124, Italy. Tel: 39 050 315 3204; Fax: 39 050 315 2166. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Single-nucleotide polymorphisms in miRNA-machinery genes may alter the biogenesis of miRNAs affecting disease susceptibility. In this case–control study, we aimed to evaluate the impact of three single-nucleotide polymorphisms (DICER rs1057035, DROSHA rs10719, and XPO5 rs11077) and their combined effect in a genetic risk score model on congenital heart disease (CHD) risk. A total of 639 participants was recruited, including 125 patients with CHD (65 males; age 9.2 ± 10 years) and 514 healthy controls (289 males; age 15.8 ± 18 years). Genotyping of polymorphisms in miRNA-machinery genes was performed using a TaqMan®SNP genotyping assay. A genetic risk score was calculated by summing the number of risk alleles of selected single-nucleotide polymorphisms. There was a significantly increased risk of CHD in patients with XPO5 rs11077 CC genotype as compared to AC heterozygote and AA homozygote patients (ORadjusted = 1.7; 95% CI: 1.1–2.8; p = 0.018). A clear tendency to significance was also found for DROSHA rs10719 AA genotype and CHD risk for both codominant and recessive models (ORadjusted = 1.8; 95% CI: 0.91–3.8; p = 0.09 and ORadjusted = 1.9; 95% CI: 0.92–4; p = 0.08, respectively). The resulting genetic risk score predicted a 1.73 risk for CHD per risk allele (95% CI: 1.2–2.5; p = 0.002). Subjects in the top tertile of genetic risk score were estimated to have more than three-fold increased risk of CHD compared with those in the bottom tertile (ORadjusted = 3.52; 95% CI: 1.4–9; p = 0.009). Our findings show that the genetic variants in miRNA-machinery genes might participate in the development of CHD.

Keywords

Congenital heart diseasesingle-nucleotide polymorphismDICERDROSHAXPO5
Type
Original Article
Information
Cardiology in the Young , Volume 31 , Issue 6 , June 2021 , pp. 965 - 968
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Andrea Borghini and Cecilia Vecoli are both first authors on this review with a shared first co-authorship.

References

Triedman, JK, Newburger, JW. Trends in congenital heart disease: the next decade. Circulation 2016; 133: 2716–2733.CrossRefGoogle ScholarPubMed
Blue, GM, Kirk, EP, Sholler, GF, Harvey, RP, Winlaw, DS. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust 2012; 197: 155–159.CrossRefGoogle ScholarPubMed
Vecoli, C, Pulignani, S, Foffa, I, Andreassi, MG. Congenital heart disease: the crossroads of genetics, epigenetics and environment. Curr Genomics 2014; 15: 390–399.CrossRefGoogle ScholarPubMed
Pulignani, S, Andreassi, MG. MicroRNAs and congenital heart disease: where are we now? Rev Esp Cardiol (Engl Ed) 2019; 72: 7–9.CrossRefGoogle ScholarPubMed
Borghini, A, Andreassi, MG. Genetic polymorphisms offer insight into the causal role of microRNA in coronary artery disease. Atherosclerosis 2018; 269: 63–70.CrossRefGoogle ScholarPubMed
Cammaerts, S, Strazisar, M, De Rijk, P, Del Favero, J. Genetic variants in microRNA genes: impact on microRNA expression, function, and disease. Front Genet 2015; 21: 186.Google Scholar
Guo, Z, Shu, Y, Zhou, H, Zhang, W. Identification of diagnostic and prognostic biomarkers for cancer: focusing on genetic variations in microRNA regulatory pathways. Mol Med Rep 2016; 13: 1943–1952.CrossRefGoogle ScholarPubMed
Ryan, BM. microRNAs in cancer susceptibility. Adv Cancer Res 2017; 135: 151–171.CrossRefGoogle ScholarPubMed
Kim, JO, Bae, J, Kim, J, et al. Association of microrna biogenesis genes polymorphisms with ischemic stroke susceptibility and post-stroke mortality. J Stroke 2018; 20: 110–121.CrossRefGoogle ScholarPubMed
Borghini, A, Pulignani, S, Mercuri, A, et al. Influence of genetic polymorphisms in DICER and XPO5 genes on the risk of coronary artery disease and circulating levels of vascular miRNAs. Thromb Res 2019; 180: 32–36.CrossRefGoogle ScholarPubMed
Pulignani, S, Vecoli, C, Borghini, A, Foffa, I, Ait-Alì, L, Andreassi, MG. Targeted next-generation sequencing in patients with non-syndromic congenital heart disease. Pediatr Cardiol 2018; 39: 682–689.CrossRefGoogle ScholarPubMed
Bartel, DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004; 116: 281–297.CrossRefGoogle ScholarPubMed
Yi, R, Doehle, BP, Qin, Y, Macara, IG, Cullen, BR. Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA 2005; 11: 220–226.CrossRefGoogle ScholarPubMed
Zeng, Y, Cullen, BR. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res 2004; 32: 4776–4785.CrossRefGoogle ScholarPubMed
Shao, Y, Shen, Y, Zhao, L, Guo, X, Niu, C, Liu, F. Association of microRNA biosynthesis genes XPO5 and RAN polymorphisms with cancer susceptibility: Bayesian hierarchical meta-analysis. J Cancer 2020; 11: 2181–2191.CrossRefGoogle ScholarPubMed
Ko, EJ, Kim, EJ, Kim, JO, et al. Analysis of the association between microRNA biogenesis gene polymorphisms and venous thromboembolism in Koreans. Int J Mol Sci 2019; 20: 15.CrossRefGoogle ScholarPubMed
Noh, H, Hong, S, Dong, Z, Pan, ZK, Jing, Q, Huang, S. Impaired MicroRNA processing facilitates breast cancer cell invasion by upregulating Urokinase-Type plasminogen activator expression. Genes Cancer 2011; 201: 140–150.CrossRefGoogle Scholar
Fan, P, Chen, Z, Tian, P, et al. miRNA biogenesis enzyme Drosha is required for vascular smooth muscle cell survival. PLoS One 2013; 18: e60888.CrossRefGoogle Scholar
Saeki, M, Watanabe, M, Inoue, N, et al. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases. Autoimmunity 2016; 49: 514–522.CrossRefGoogle ScholarPubMed
Wen, J, Lv, Z, Ding, H, Fang, X, Sun, M. Association of miRNA biosynthesis genes DROSHA and DGCR8 polymorphisms with cancer susceptibility: a systematic review and meta-analysis. Biosci Rep 2018; 38: 3.Google ScholarPubMed
Lee, AE, Ryu, CS, Kim, JO, et al. Association between microRNA machinery gene polymorphisms and recurrent implantation failure. Exp Ther Med 2020; 4: 3113–3123.Google Scholar
Xu, M, Ma, L, Lou, S, et al. Genetic variants of microRNA processing genes and risk of non-syndromic orofacial clefts. Oral Dis 2018; 24: 422–428.CrossRefGoogle ScholarPubMed
Barritt, LC, Miller, JM, Scheetz, LR, et al. Conditional deletion of the human ortholog gene Dicer1 in Pax2-Cre expression domain impairs orofacial development. Indian J Hum Genet 2012; 18: 310–319.Google ScholarPubMed
Zehir, A, Hua, LL, Maska, EL, Morikawa, Y, Cserjesi, P. Dicer is required for survival of differentiating neural crest cells. Dev Biol 2010; 340: 459–467.CrossRefGoogle ScholarPubMed
Zhao, Y, Ransom, JF, Li, A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 2007; 129: 303–317.CrossRefGoogle ScholarPubMed
Saxena, A, Tabin, CJ. miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation. Proc Natl Acad Sci USA 2010; 107: 87–91.CrossRefGoogle ScholarPubMed
Sabbaghian, N, Digilio, MC, Blue, GM, Revil, T, Winlaw, DS, Foulkes, WD. Analysis of DICER1 in familial and sporadic cases of transposition of the great arteries. Congenit Heart Dis 2018; 13: 401–406.CrossRefGoogle ScholarPubMed
Ma, H, Yuan, H, Yuan, Z, et al. Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population. PLoS One 2012; 7: e47544.CrossRefGoogle ScholarPubMed
Yu, YY, Kuang, D, Yin, XX. Association between the DICER rs1057035 polymorphism and cancer risk: evidence from a meta-analysis of 1,2675 individuals. Asian Pac J Cancer Prev 2015; 16: 119–124.CrossRefGoogle ScholarPubMed